Your session is about to expire
← Back to Search
Usual Care for Cervical Cancer (STEP Trial)
STEP Trial Summary
This trial will compare how well different outreach approaches work in getting women to do home-based HPV tests for cervical cancer screening, and whether these approaches are cost-effective.
- Cervical Cancer
- Uterine Diseases
- Cervical Carcinoma
- HPV-Related Malignancy
- Cervical Diseases
- Tumors
- Urogenital Neoplasms
- Uterine Cancer
- Genital Warts
- Cervical Dysplasia
- Human Papillomavirus
STEP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.STEP Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this trial available to individuals over the age of 45?
"As per the criteria for enrollment, individuals aged 30-64 are eligible to partake in this medical trial. 342 other trials target those under 18 and 2633 focus on senior citizens over 65."
Who is an eligible candidate for this medical experiment?
"The recruitment phase of this trial is accepting 32623 participants aged between 30 and 64 with uterine cervical diseases. Qualifying individuals must also be women in the noted age bracket."
Is there currently an enrollment period for this experiment?
"At present, this clinical trial is not actively recruiting. Originally posted on November 20th 2020 and last updated on August 16th 2021, it has been determined that the study does not require additional participants. Fortunately, there are still 2,905 other medical trials searching for volunteers at the moment."
What is the ultimate goal of this research endeavor?
"The primary intent of this trial, which will take around 6 months to monitor, is to measure the incremental cost-effectiveness ratio through outreach and pre-screening behavior. Secondary goals include determining the proportion of patients in the intervention group who return their home kits or receive an in clinic screening with regards to current medical guidelines; calculating how many participants do not screen at all based on outreach methodology and prior screenings; and timing from randomization to when participants initiate/have access to screenings by both outreach approach and previous screenings."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger